Time-cap Labs Inc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Time-cap Labs Inc Pharmaceutical Import Records from India — 2 Products, $12.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Time-cap Labs Inc — Pharmaceutical Importer Profile (2026) | 2 Products, $12.6M Trade | TransData Nexus

Time-cap Labs Inc

Pharmaceutical Importer · United States · Analgesics & Antipyretics Focus · $12.6M Total Trade · DGFT Verified

Time-cap Labs Inc is a pharmaceutical importer based in United States with a total trade value of $12.6M across 2 products in 1 therapeutic categories. Based on 339 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Time-cap Labs Inc sources from 1 verified Indian supplier, with Marksans Pharma Limited accounting for 100.0% of imports.

Time-cap Labs Inc — Import Portfolio & Supplier Network

Time-cap Labs Inc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Time-cap Labs Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Marksans Pharma Limited	$18.8M	722	100.0%

Time-cap Labs Inc sources from 1 verified Indian supplier across 546 distinct formulations. The sourcing is highly concentrated — Marksans Pharma Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Time-cap Labs Inc Import?

Formulation	Value	Ships
Ibuprofen soft gelatin capsules 200MG	$368.9K	9
Ibuprofen soft gelatin capsules 200 MG	$247.8K	5
Metformin hydrochloride TAB USP 1000MG	$232.0K	5
Daytime cold&flu multi-sytm relief	$208.2K	7
Ibuprofen tablets USP 200 MG (8683200	$200.0K	4
Cold&flu daytime sev & nighttime sev	$186.1K	8
Ibuprofen tablets USP 200 MG (4320000	$179.3K	6
Daytime & nighttime cold&flu mul-sytm	$179.1K	6
Ibuprofen tablets USP 800MG (4152000 TAB	$150.0K	3
Cetirizine hydrochloride tablets usp10mg	$138.3K	5
Heb day/night combo softgel 48s	$132.3K	3
Ibuprofen tablets USP 200 MG batch no	$123.3K	3
Ibuprofen soft gelatin capsules 200MG	$122.9K	3
Ibuprofen soft gelatin capsules 200MG batch no	$107.4K	3
Ibuprofen soft gelatin capsules 200MG batch no	$106.6K	3

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ibuprofen	Analgesics & Antipyretics	$10.8M	274	1.8%	9
2	Acetaminophen	Analgesics & Antipyretics	$1.8M	65	0.8%	17

Time-cap Labs Inc imports 2 pharmaceutical products across 1 categories into United States totaling $12.6M.

Time-cap Labs Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Time-Cap Labs Inc. is a U.S.-based pharmaceutical manufacturer specializing in solid-dose generic drugs, over-the-counter (OTC) medications, and nutritional supplements. Established in 1978, the company operates a state-of-the-art facility in Farmingdale, New York, producing a diverse range of products, including tablets, capsules, and softgels. Time-Cap Labs serves major retailers and pharmaceutical distributors, offering both branded and private label solutions.

In July 2015, Time-Cap Labs was acquired by Marksans Pharma, an Indian pharmaceutical company, through its wholly owned subsidiary Marksans Pharma Inc. This acquisition, valued at $28 million, provided Marksans Pharma with an ideal platform to expand its operations in the U.S. market. The acquisition enabled Marksans to enhance its manufacturing capabilities and product portfolio, particularly in the solid dosage form segment.

2Distribution Network

Time-Cap Labs operates a manufacturing facility located at 7 Michael Avenue, Farmingdale, NY 11735. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic acquisition by Marksans Pharma suggests an integrated distribution network that leverages Marksans' global resources. This integration likely enhances Time-Cap Labs' ability to distribute products efficiently across the United States and potentially to international markets.

3Industry Role

Time-Cap Labs Inc. functions as a pharmaceutical manufacturer specializing in the production of generic drugs, OTC medications, and nutritional supplements. The company offers private label manufacturing services, enabling retailers to develop store brands and enhance customer loyalty. By providing both branded and private label products, Time-Cap Labs plays a significant role in the U.S. pharmaceutical supply chain, catering to a wide range of consumer needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Time-cap Labs Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Time-Cap Labs Inc. has a notable sourcing concentration, importing a total of $12.6 million worth of finished pharmaceutical formulations from India over 339 shipments. The company's portfolio is highly concentrated, with the top five products accounting for 100% of the imported value. This concentration indicates a strategic choice to maintain a focused product line, potentially streamlining operations and ensuring quality control. However, such dependency on a single supplier, MARKSANS PHARMA LIMITED, which accounts for 100% of the shipments, could pose risks related to supply chain disruptions or changes in supplier dynamics.

2Supply Chain Resilience

The resilience of Time-Cap Labs' Indian supply chain is closely tied to its exclusive relationship with MARKSANS PHARMA LIMITED. This single-source dependency may limit the company's ability to diversify its supply chain and mitigate risks associated with supplier-specific issues. The lack of publicly available information on backup suppliers and formulation diversity suggests potential vulnerabilities in the supply chain. Additionally, the company's reliance on a single supplier may expose it to risks related to shipping route disruptions and regulatory compliance challenges.

Strategic Implications

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) is the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth requirements for the safety, efficacy, and quality of drugs imported into the U.S. Pharmaceutical imports must comply with FDA standards, including proper labeling, manufacturing practices, and approval processes.

2Import Licensing & GMP

Importers of pharmaceutical products into the United States must adhere to FDA regulations, including obtaining necessary import licenses and ensuring that imported drugs meet Good Manufacturing Practice (GMP) standards. The FDA recognizes GMP certifications from various international bodies, such as the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Compliance with these standards is essential for the importation and distribution of pharmaceutical products in the U.S. market.

3Quality & Labeling

Time-cap Labs Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Time-Cap Labs Inc. focuses on importing finished pharmaceutical formulations, specifically analgesics and antipyretics, from India. The company's top imported products include ibuprofen and acetaminophen, which are widely used for pain relief and fever reduction. The demand for these products in the U.S. market is driven by their common use in treating various conditions, making them essential components of Time-Cap Labs' product portfolio.

2Sourcing Profile

Time-Cap Labs' sourcing strategy centers on importing generic drug formulations from India, particularly in the analgesics and antipyretics categories. The company's exclusive relationship with MARKSANS PHARMA LIMITED indicates a strategic choice to maintain a focused and streamlined supply chain. This approach allows Time-Cap Labs to leverage the manufacturing capabilities and expertise of its supplier while ensuring product quality and consistency.

3Market Positioning

Based on its product mix, Time-Cap Labs Inc. serves the U.S. market through wholesale distribution channels. By providing both branded and private label products, the company caters to a wide range of consumer needs, including those of retail pharmacies, hospital suppliers, and government tenders. This diverse approach enables Time-Cap Labs to maintain a significant presence in the pharmaceutical supply chain.

Seller's Guide — How to Become a Supplier to Time-cap Labs Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Time-Cap Labs Inc., especially if they can meet the company's stringent quality standards and regulatory requirements. Diversifying the supplier base could enhance supply chain resilience and mitigate risks associated with single-source dependency. However, any new supplier would need to demonstrate the capability to deliver consistent quality and reliability to align with Time-Cap Labs' operational standards.

2Requirements & Qualifications

Indian exporters seeking to supply Time-Cap Labs Inc. and the U.S. market must adhere to FDA regulations, including obtaining necessary import licenses and ensuring compliance with GMP standards recognized by the FDA. Additionally, products must meet FDA labeling requirements, which include truthful and informative labeling in English. Maintaining high-quality manufacturing practices and obtaining relevant certifications are essential for successful market entry.

3How to Approach

Frequently Asked Questions — Time-cap Labs Inc

What products does Time-cap Labs Inc import from India?

Time-cap Labs Inc imports 2 pharmaceutical products across 1 categories. Top imports: Ibuprofen ($10.8M), Acetaminophen ($1.8M).

Who supplies pharmaceuticals to Time-cap Labs Inc from India?

Time-cap Labs Inc sources from 1 verified Indian suppliers. The primary supplier is Marksans Pharma Limited (100.0% of imports, $18.8M).

What is Time-cap Labs Inc's total pharmaceutical import value?

Time-cap Labs Inc's total pharmaceutical import value from India is $12.6M, based on 339 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Time-cap Labs Inc focus on?

Time-cap Labs Inc imports across 1 categories. The largest: Analgesics & Antipyretics (100.0%).

Get Full Time-cap Labs Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.